Proactive Investors - Run By Investors For Investors

CB2 Insights ready to move to Phase two of study with primary care physicians tool

CB2 Insights (CSE: CBII) CEO Prad Sekar joined Steve Darling from Proactive Investors Vancouver to discuss the company moving into phase 2 of the integration of their program into the Juno platform.

Sekar tells Proactive about the results of phase 1 and what they were hearing from Physicians using the system. 

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here  
View full CBII profile View Profile

CB2 Insights Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use